Literature DB >> 11987262

Evolution of colorectal cancer: change of pace and change of direction.

Jereny R Jass1, Joanne Young, Barbara A Leggett.   

Abstract

This review compiles evidence for an alternative to the classical adenoma-carcinoma sequence in the evolution of colorectal cancer. It is suggested that between 30 and 50 of colorectal cancers are not initiated by mutation of the tumor suppressor gene APC, but through the epigenetic silencing of genes implicated in the control of differentiation, cell cycle control and DNA repair proficiency. The precursor polyps are often characterized by a serrated architecture, and include hyperplastic polyps, admixed polyps and serrated adenomas. The alternative pathway is heterogeneous and may culminate in cancers showing low or high level DNA microsatellite instability (MSI-L and MSI-H, respectively), and in cancers that are microsatellite stable (MSS). Cancers showing DNA MSI may be characterized by an accelerated evolution. Cancers in hereditary non-polyposis colorectal cancer show features of both classical (adenoma and APC mutation) and alternative pathways (rapid evolution, MSI-H and lack of chromosomal instability).

Entities:  

Mesh:

Year:  2002        PMID: 11987262     DOI: 10.1046/j.1440-1746.2002.02635.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  27 in total

Review 1.  Serrated adenoma of the colorectum: a lesion with teeth.

Authors:  Jeremy R Jass
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 2.  [Carcinogenesis and hereditart colon cancers].

Authors:  F Kullmann
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

Review 3.  Tumour budding in colorectal cancer: what do we know and what can we do?

Authors:  Linde De Smedt; Sofie Palmans; Xavier Sagaert
Journal:  Virchows Arch       Date:  2015-11-27       Impact factor: 4.064

Review 4.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

Review 5.  A review of spatial computational models for multi-cellular systems, with regard to intestinal crypts and colorectal cancer development.

Authors:  Giovanni De Matteis; Alex Graudenzi; Marco Antoniotti
Journal:  J Math Biol       Date:  2012-05-08       Impact factor: 2.259

6.  Racial differences in the anatomical distribution of colorectal cancer: a study of differences between American and Chinese patients.

Authors:  San-Hua Qing; Kai-Yun Rao; Hui-Yong Jiang; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 7.  MicroRNAs are important regulators of drug resistance in colorectal cancer.

Authors:  Yang Zhang; Jing Wang
Journal:  Biol Chem       Date:  2017-07-26       Impact factor: 3.915

8.  Serrated polyps of the colon: how reproducible is their classification?

Authors:  Arzu Ensari; Banu Bilezikçi; Fatima Carneiro; Gülen Bülbül Doğusoy; Ann Driessen; Ayşe Dursun; Jean-François Flejou; Karel Geboes; Gert de Hertogh; Anne Jouret-Mourin; Cord Langner; Irıs D Nagtegaal; Johan Offerhaus; Janina Orlowska; Ari Ristimäki; Julian Sanz-Ortega; Berna Savaş; Maria Sotiropoulou; Vincenzo Villanacci; Nazmiye Kurşun; Fred Bosman
Journal:  Virchows Arch       Date:  2012-10-06       Impact factor: 4.064

9.  Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang; An-Long Zhu; Lin-Feng Wu; Shu-Yi Qi; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  APC mutation and tumour budding in colorectal cancer.

Authors:  J R Jass; M Barker; L Fraser; M D Walsh; V L J Whitehall; B Gabrielli; J Young; B A Leggett
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.